Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Christie L. Carroll"'
Autor:
Audrey W H Tan, Patricia Pei-Lin Ng, Catherine G Manabat, Christie L. Carroll, Yiong Huak Chan, Ajith Kannagra, Gil Yosipovitch, Joseph L. Jorizzo, Katherine LoSicco
Publikováno v:
International Journal of Dermatology. 52:813-819
Background To date, no study has compared the clinical characteristics, malignancy associations, and treatment of dermatomyositis in predominantly Caucasian vs. Asian populations. Materials and methods This prospective study was conducted to compare
Autor:
Fabian Camacho, Amy L. Gosnell, Ann Boles, Christie L. Carroll, Daniel J. Pearce, Mandeep Kaur, Steven R. Feldman, Alan B. Fleischer
Publikováno v:
Psoriasis Forum. :10-13
Background The biological agent alefacept (Amevive) induces sustained clinical improvement in patients with chronic plaque-type psoriasis.1 Multiple or extended courses of therapy are associated with higher response rates and an increased duration of
Autor:
J.P. Callen, Christie L. Carroll, Beverly M. Snively, Wei Lang, Steven R. Feldman, Joseph L. Jorizzo
Publikováno v:
British Journal of Dermatology. 158:345-350
Summary Background Dermatomyositis is an autoimmune inflammatory muscle disease with characteristic cutaneous findings of heliotrope eruption, Gottron’s papules and a photodistributed eruption with poikiloderma. Objectives To develop and validate a
Autor:
Christie L. Carroll, Aerlyn G. Dawn, Yiong Huak Chan, Kimberly A. Cayce, Maria L. Duque, Joseph L. Jorizzo, Gil Yosipovitch, Suganthi Thevarajah
Publikováno v:
Skin Research and Technology. 13:285-292
Background: Several studies using nailfold capillary microscopes have demonstrated capillary changes in patients with dermatomyositis (DM); however, no previous study has examined cutaneous blood flow in this disease. Purpose: To determine cutaneous
Autor:
Steven R. Feldman, Christie L. Carroll, Mandeep Kaur, Rajesh Balkrishnan, Mark G. Tusa, David R. Carr, Alan B. Fleischer, Fabian Camacho, Jennifer Krejci-Manwaring
Publikováno v:
Journal of the American Academy of Dermatology. 56:211-216
Background Atopic dermatitis is a common problem for which topical agents are the primary treatment. When topical medications fail, further therapy may include systemic agents with the potential for greater toxicity. Adherence to topical treatment of
Autor:
Steven R. Feldman, Christie L. Carroll, Beverly M. Snively, Wei Lang, Joseph L. Jorizzo, Gil Yosipovitch, Jennifer L. Hundley
Publikováno v:
Journal of the American Academy of Dermatology. 54:217-220
Background Dermatomyositis affects visible skin and causes disease symptoms that can affect patients' quality of life (QOL). Methods In all, 71 patients with dermatomyositis or dermatomyositis sine myositis completed two QOL measures (the Skindex-16
Autor:
Kafele T Hodari, Jaleema R Nanton, Steven R. Feldman, Rajesh Balkrishnan, Christie L. Carroll
Publikováno v:
Journal of Dermatological Treatment. 17:136-142
Adherence has been studied in many areas of medicine; however, there are few published articles pertaining to adherence and dermatology.The purpose of this review is to summarize the current literature on medical adherence as it specifically applies
Autor:
Christie L. Carroll, Alan B. Fleischer
Publikováno v:
Expert Opinion on Pharmacotherapy. 5:2127-2137
Topical tacrolimus (FK506, Protopic) has been developed and marketed for the treatment of atopic dermatitis (AD). Tacrolimus works as an inhibitor of calcineurin, which creates a downregulation of the inflammatory cascade. Numerous trials have shown
Publikováno v:
Journal of the American Academy of Dermatology. 51:212-216
Medication nonadherence is common throughout medicine, and research into this area is increasing; however, knowledge about topical medication adherence is limited.A total of 30 patients were enrolled in a clinical trial for psoriasis and followed up
Autor:
Christie L. Carroll, Jennifer Krejci-Manwaring, Rajesh Balkrishnan, Fabian Camacho, Steven R. Feldman
Publikováno v:
Journal of the American Academy of Dermatology. 57:81-83
Background The efficacy of topical medications is limited by non-adherence. Interventions to improve adherence to topical treatments are not well characterized. Objective To assess the impact of office visits on patients' adherence to topical treatme